ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,919Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 229

$380K Total Retail Price of All Prescriptions

Rank: 75 out of 229

427 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 427 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 427 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 5,420 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 307 269 1 2
LEVOTHYROXINE SODIUM 285 238 2 1
OMEPRAZOLE 240 196 3 4
SIMVASTATIN 234 217 4 3
AMLODIPINE BESYLATE 212 171 5 5
HYDROCODONE-ACETAMINOPHEN 176 110 S3 6 7
ZOLPIDEM TARTRATE 172 117 7 20
RANITIDINE HCL 163 112 8 32
HYDROCHLOROTHIAZIDE 146 107 9 9
BENAZEPRIL HCL 143 120 10 86
LOSARTAN POTASSIUM 138 107 11 12
PRAVASTATIN SODIUM 120 111 12 25
METFORMIN HCL 116 92 13 6
OXYCODONE-ACETAMINOPHEN 114 51 S2 14 43
FUROSEMIDE 106 96 15 8
ALENDRONATE SODIUM 104 101 16 14
METOPROLOL TARTRATE 104 92 16 13
METOPROLOL SUCCINATE 100 99 18 16
CRESTOR 99 93 19 30
ATORVASTATIN CALCIUM 98 63 20 15
TAMSULOSIN HCL 97 90 21 24
SERTRALINE HCL 92 67 22 22
LOVASTATIN 89 79 23 11
METFORMIN HCL ER 86 71 24 77
TRAMADOL HCL 81 60 25 26
LOSARTAN-HYDROCHLOROTHIAZIDE 77 56 26 65
TRAZODONE HCL 77 57 26 34
MELOXICAM 74 47 28 45
FELODIPINE ER 70 65 29 61
WARFARIN SODIUM 67 65 30 17
POTASSIUM CHLORIDE 62 50 31 18
GABAPENTIN 62 48 31 10
SPIRIVA 60 55 33 76
CITALOPRAM HBR 57 42 34 21
CARVEDILOL 54 43 35 31
ALLOPURINOL 51 45 36 27
FINASTERIDE 50 50 37 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.